CSI Market
Sign In | Register

Proqr Therapeutics N v (PRQR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PRQR Annual Balance Sheets →
The data below summarizes Proqr Therapeutics N v's balance sheet position from Dec 31 2024 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents103.50
Cash & Short-term Investments103.00
Other Current Assets8.64
Total Current Assets112.14
Other Assets, Noncurrent14.15
Total Assets126.29
Liabilities
Other Liabilities, Current36.33
Total Current Liabilities36.33
Total Long-term Debt0.00
Other liabilities, Noncurrent34.65
Total Liabilities70.99
Stockholders' Equity
Other Equity55.30
Common Stockholder's Equity55.30
Total Stockholder's Equity55.30
Liabilities & Stockholder's Equity126.29
4 historic quarters locked

Sign in to unlock the full Proqr Therapeutics N v balance sheet history.

Sign In Create Free Account

About Proqr Therapeutics N v Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-026713

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.